A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
Completed · Not applicable
Conditions studied: Neoplasms
In brief
This protocol allows subjects who have participated in a previous SU011248 protocol the ability to continue to receive SU011248 after their study has ended.
Key facts
- Study ID
- NCT00443534
- Run by
- Pfizer
- People needed
- 123
- Starts
- 2006-05-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2013-05-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participation in a previous SU011248 protocol and are judged by the investigator to have the potential to derive clinical benefit by remaining on SU011248 after the prior protocol ends.
You may not qualify if…
- Severe acute or chronic medical or psychiatric condition, or laboratory abnormality that may increase the risk associated with study participation or study drug administration, or may interfere with the interpretation of study results, and in the judgment of the investigator would make the patient inappropriate for entry into this study.
Where it is running
- Pfizer Investigational Site — Littleton, Colorado, United States
- Pfizer Investigational Site — Orlando, Florida, United States
- Pfizer Investigational Site — Atlanta, Georgia, United States
- Pfizer Investigational Site — Harvey, Illinois, United States
- Pfizer Investigational Site — Harvey, Illinois, United States
- Pfizer Investigational Site — Maywood, Illinois, United States
- Pfizer Investigational Site — Tinley Park, Illinois, United States
- Pfizer Investigational Site — Zion, Illinois, United States
- Pfizer Investigational Site — Munster, Indiana, United States
- Pfizer Investigational Site — Baltimore, Maryland, United States
- Pfizer Investigational Site — Grand Rapids, Michigan, United States
- Pfizer Investigational Site — City of Saint Peters, Missouri, United States
- Pfizer Investigational Site — Creve Coeur, Missouri, United States
- Pfizer Investigational Site — St Louis, Missouri, United States
- Pfizer Investigational Site — Las Vegas, Nevada, United States
- Pfizer Investigational Site — Hackensack, New Jersey, United States
- Pfizer Investigational Site — Chapel Hill, North Carolina, United States
- Pfizer Investigational Site — Clinton, North Carolina, United States
- Pfizer Investigational Site — Goldsboro, North Carolina, United States
- Pfizer Investigational Site — Hickory, North Carolina, United States
- Pfizer Investigational Site — Wilson, North Carolina, United States
- Pfizer Investigational Site — Oklahoma City, Oklahoma, United States
- Pfizer Investigational Site — Tulsa, Oklahoma, United States
- Pfizer Investigational Site — Tulsa, Oklahoma, United States
- Pfizer Investigational Site — Aurora, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.